Skip to main content

Head-to-head comparison

incyte vs quintiles

quintiles leads by 10 points on AI adoption score.

incyte
Biopharmaceuticals · wilmington, delaware
75
B
Moderate
Stage: Adopting
Key opportunity: AI can accelerate oncology drug discovery by predicting compound efficacy and patient response biomarkers, dramatically reducing R&D timelines and costs.
Top use cases
  • AI-Driven Drug Discovery
  • Clinical Trial Optimization
  • Biomarker Identification
View full profile →
quintiles
Pharmaceutical research & clinical services · durham, north carolina
85
A
Advanced
Stage: Mature
Key opportunity: AI can accelerate drug development by predicting clinical trial outcomes, optimizing patient recruitment, and analyzing complex biomarker data to reduce trial timelines and costs.
Top use cases
  • Predictive Patient Recruitment
  • Clinical Data Review Automation
  • Trial Site Optimization
View full profile →
vs

Want a private comparison report?

We'll benchmark your company against up to 5 peers with a detailed AI adoption assessment.

Request report →